Healthy uptrend? Yes
Retracement? Yes
With every retracement candle, we move our buy limit order at candle's high. So the first order we placed at 1. In a way, we are telling the broker to buy when the price crosses 1.

Tata Elxsi ---
— Steve Nison (@nison_steve) June 30, 2021
In the last 10 minutes, all the selling was absorbed despite intraday positions being squared off (if not converted). will wait for the EOD data. However, the chart structure is extremely strong. https://t.co/pci7GCDBEO pic.twitter.com/1NBD9V3mKc
Learning: Strong breakout
— The_Chartist \U0001f4c8 (@nison_steve) July 2, 2021
1. Breakout candle will have no upper shadow or extremely less compared to the body
2. Volumes will be high (to avoid retailers to enter & also big hand absorbing all the selling)
3. Pullbacks will be rare/very less
4. Happens after a long consolidation pic.twitter.com/YTHDOnEdxo
Sir Edwards & Magee discussed sloping necklines in H&S in their classical work. I am considering this breakdown by Affle as an H&S top breakdown with a target open of 770.
— The_Chartist \U0001f4c8 (@charts_zone) May 25, 2022
The target also coincides with support at the exact same level. pic.twitter.com/n84kSgkg4q
1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 30, 2021
"we generated a mouse model expressing hACE2 by using CRISPR/Cas9 knockin technology. In comparison with wild-type C57BL/6 mice, both young & aged hACE2 mice sustained high viral loads... pic.twitter.com/j94XtSkscj
1. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2!
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 2, 2021
2 papers:
Human\u2013viral molecular mimicryhttps://t.co/irfH0Zgrve
Molecular Mimicryhttps://t.co/yLQoUtfS6s https://t.co/lsCv2iMEQz
If everyone was holding bitcoin on the old x86 in their parents basement, we would be finding a price bottom. The problem is the risk is all pooled at a few brokerages and a network of rotten exchanges with counter party risk that makes AIG circa 2008 look like a good credit.
— Greg Wester (@gwestr) November 25, 2018